1. Home
  2. AMRX vs COGT Comparison

AMRX vs COGT Comparison

Compare AMRX & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

SELL

Current Price

$21.23

Market Cap

6.4B

Sector

Health Care

ML Signal

SELL

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

SELL

Current Price

$27.46

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AMRX
COGT
Founded
2002
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.5B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
AMRX
COGT
Price
$21.23
$27.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
12
Target Price
$24.29
★ $55.82
AVG Volume (30 Days)
★ 3.5M
2.0M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 157.89
N/A
EPS
★ 0.29
N/A
Revenue
N/A
★ $7,871,000.00
Revenue This Year
$6.38
N/A
Revenue Next Year
$9.21
$5,819.52
P/E Ratio
$73.78
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.39
$27.74
52 Week High
$22.07
$43.73

Technical Indicators

Market Signals
Indicator
AMRX
COGT
Relative Strength Index (RSI) 57.02 37.79
Support Level $18.90 N/A
Resistance Level $21.21 $37.34
Average True Range (ATR) 0.86 1.81
MACD 0.04 -0.30
Stochastic Oscillator 71.96 4.41

Price Performance

Historical Comparison
AMRX
COGT

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: